Dif­ferin mak­er Gal­der­ma wins FDA ap­proval for a new retinoid for ac­ne

Da­ta sug­gest that in 2016 the bur­den of ac­ne vul­garis — the chron­ic in­flam­ma­to­ry skin dis­ease — bal­looned to rough­ly $3 bil­lion in health­care costs and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.